CVE-2026-76190: high-severity vulnerability in Adobe ColdFusion 2023
ColdFusion | Improper Neutralization of Directives in Dynamically Evaluated Code ('Eval Injection') (CWE-95)
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 8.6epss 0.8%
ColdFusion is affected by an Improper Neutralization of Directives in Dynamically Evaluated Code ('Eval Injection') vulnerability that could result in arbitrary code execution in the context of the current user. An attacker could exploit this vulnerability to execute arbitrary code. Exploitation of this issue does not require user interaction. Scope is changed.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N
Related CVEs — Adobe ColdFusion 2023
In the same product, most dangerous first.
CVE-2026-48282CRITICALColdFusion | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CWE-22)EPSS 42.4%KEVCVE-2026-27305HIGHColdFusion | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CWE-22)EPSS 26.3%CVE-2026-34619HIGHColdFusion | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CWE-22)EPSS 7.6%CVE-2026-27304CRITICALColdFusion | Improper Input Validation (CWE-20)EPSS 3.6%CVE-2026-48362CRITICALColdFusion | Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') (CWE-78)EPSS 3.5%CVE-2026-48313CRITICALColdFusion | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CWE-22)EPSS 3.0%